Phenoxybenzamine and benextramine, but not 4-diphenylacetoxy-N-[2-chloroethyl]piperidine hydrochloride, display irreversible noncompetitive antagonism at G protein-coupled receptors.

Abstract

Many irreversible antagonists have been shown to inactivate G protein-coupled receptors (GPCRs) and used to study agonists and spare receptors. Presumably, they bind to primary (agonist) binding sites on the GPCR, although noncompetitive mechanisms of antagonism have been demonstrated but not thoroughly investigated. We studied noncompetitive antagonism by phenoxybenzamine and benextramine at alpha(2A)-adrenoceptors in stably transfected Chinese hamster ovary cells, benextramine and 4-diphenylacetoxy-N-[2-chloroethyl]piperidine hydrochloride (4-DAMP mustard) at endogenous muscarinic acetylcholine (mACh) receptors in human neuroblastoma SH-SY5Y cells, and benextramine at serotonin 5-HT(2A) receptors in stably transfected SH-SY5Y cells. Primary binding sites were protected by reversible competitive antagonists during pretreatment with irreversible antagonists. We conducted appropriate radioligand binding assays by measuring remaining primary binding sites and agonist affinity, functional assays to evaluate agonist-induced responses, and constitutive guanosine 5'-O-(3-[(35)S]thio)triphosphate ([(35)S]GTPgammaS)-Galpha(o) binding assays to determine remaining G protein activity. Phenoxybenzamine (100 microM; 20 min) and benextramine (10 or 100 microM; 20 min) at alpha(2A)-adrenoceptors, but not 4-DAMP mustard (100 nM; 120 min) at mACh receptors, displayed irreversible noncompetitive antagonism in addition to their known irreversible competitive antagonism. Although agonist binding affinity is not influenced, signal transduction is modulated in a G protein-dependent manner via allotopic interactions. Benextramine noncompetitively inhibits agonist-induced responses at three different GPCR types (alpha(2A), mACh, and 5-HT(2A) receptors) that signal via three families of G proteins (G(i/o), G(s), and G(q/11)). We conclude that, where irreversible antagonists are utilized to study drug-receptor interaction mechanisms, the presence of significant irreversible noncompetitive antagonism may influence the interpretation of results under the experimental conditions used.

• Authors: Johannes Bodenstein, Daniel P Venter, Christiaan B Brink
• Journal: The Journal of pharmacology and experimental therapeutics (J Pharmacol Exp Ther) Vol. 314 Issue 2 Pg. 891-905 (Aug 2005) ISSN: 0022-3565 [Print] United States
• PMID: 15857948 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)

Chemical References

• Adrenergic alpha-Agonists
• Adrenergic alpha-Antagonists
• Diphenylacetic Acids
• Inositol Phosphates
• Ligands
• Piperidines
• Receptor, Serotonin, 5-HT2A
• Receptors, G-Protein-Coupled
• Receptors, Muscarinic
• Serotonin Receptor Agonists
• Phenoxybenzamine
• N-(2-chloroethyl)-4-piperidinyl diphenylacetate
• benextramine
• Cyclic AMP
• GTP-Binding Protein alpha Subunits, Gi-Go
• GTP-Binding Protein alpha Subunits, Gq-G11
• GTP-Binding Protein alpha Subunits, Gs
• Cystamine

Topics

• Adrenergic alpha-Agonists (pharmacology)
• Adrenergic alpha-Antagonists (pharmacology)
• Animals
• Binding, Competitive (drug effects)
• CHO Cells
• Cell Line
• Cell Line, Tumor
• Cricetinae
• Cyclic AMP (metabolism)
• Cystamine (analogs & derivatives, pharmacology)
• Diphenylacetic Acids (pharmacology)
• GTP-Binding Protein alpha Subunits, Gi-Go (metabolism)
• GTP-Binding Protein alpha Subunits, Gq-G11 (metabolism)
• GTP-Binding Protein alpha Subunits, Gs (metabolism)
• Humans
• Inositol Phosphates (metabolism)
• Ligands
• Phenoxybenzamine (pharmacology)
• Piperidines (pharmacology)
• Receptor, Serotonin, 5-HT2A (drug effects)
• Receptors, G-Protein-Coupled (antagonists & inhibitors)
• Receptors, Muscarinic (drug effects)
• Second Messenger Systems (drug effects)
• Serotonin Receptor Agonists (pharmacology)
• Signal Transduction (drug effects)